Design of B‐Cell Multi‐Epitope Subunit Vaccines Against Glaesserella parasuis by Reverse Vaccinology: An In Silico and In Vivo Study
Transboundary and Emerging Diseases · 2026
DOI: 10.1155/tbed/5696948 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, 2026. Verfasst von Yan Gong und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Educ…. Hauptthemen laut MEDLINE: Vaccines, Subunit, Haemophilus parasuis, Haemophilus Infections, Swine Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Glässer’s disease caused by Glaesserella parasuis (GPS) is a severe disease that results in substantial economic losses to the swine industry worldwide. Here we describe a multiepitope vaccine cocktail (MEVC) that was designed using reverse vaccinology and immunoinformatics. The MEVC was comprised of three multiepitope subunits (MESs, designated as TB, 14B, and 24B), which were constructed using 14 B‐cell epitopes predicted from six outer membrane antigens of GPS. The MESs exhibited non‐allergenicity, high antigenicity, solubility, and stability. Predicted secondary and tertiary structures of the MESs were validated and showed strong binding affinity with the swine leukocyte antigen (SLA) by molecular docking. Immune simulation analysis further confirmed robust induction of both cellular and humoral immune responses. Immunization with MESs plus Gel‐01 adjuvant (MEVC) resulted in 80% protection against GPS5 infection in mice, along with significantly increased antigen‐specific IgG levels compared to controls. In conclusion, MEVC is a promising vaccine candidate to protect against porcine Glasser’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jili…
- Department of Rehabilitation, The Second Hospital of Jilin University, Changchun, China, jlu.edu.cn.
- College of Animal Science and Technology, Yangtze University, Jingzhou, China, yangtzeu.edu.cn.
- Haid Research Institute, Guangdong Haid Group Co., Ltd., Guangzhou, China.
ORCID-Profile: Fengyang Li, Liancheng Lei
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Gong, Y., Li, N., Li, Z., Wang, H., Zhang, D., Chu, H., Lu, Z., Jia, A., Li, F., & Lei, L. (2026). Design of B‐Cell Multi‐Epitope Subunit Vaccines Against Glaesserella parasuis by Reverse Vaccinology: An In Silico and In Vivo Study. Transboundary and Emerging Diseases. https://doi.org/10.1155/tbed/5696948
Vancouver
Gong Y, Li N, Li Z, Wang H, Zhang D, Chu H, et al. Design of B‐Cell Multi‐Epitope Subunit Vaccines Against Glaesserella parasuis by Reverse Vaccinology: An In Silico and In Vivo Study. Transboundary and Emerging Diseases. 2026. doi:10.1155/tbed/5696948
BibTeX
@article{Gong2026,
author = {Gong, Yan and Li, Na and Li, Ziheng and Wang, He and Zhang, Di and Chu, Hong and Lu, Zhichao and Jia, Aiqing and Li, Fengyang and Lei, Liancheng},
title = {Design of B‐Cell Multi‐Epitope Subunit Vaccines Against Glaesserella parasuis by Reverse Vaccinology: An In Silico and In Vivo Study},
journal = {Transboundary and Emerging Diseases},
year = {2026},
doi = {10.1155/tbed/5696948}
}
EUVIMED